Related Experiment Video
Updated: Jul 2, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
DNA vaccination and gene therapy: optimization and delivery for cancer therapy
Angela M Bodles-Brakhop1, Ruxandra Draghia-Akli
1VGX Pharmaceuticals Inc., 2700 Research Forest Drive, Suite 180, The Woodlands, TX 77381, USA. abrakhop@vgxp.com
Abstract:
This review will focus on DNA vaccine approaches for the prevention or treatment of cancer and its complications. DNA vaccine therapies are a relatively novel method of cancer treatment with the goal to induce immunity against tumor-associated antigens. Both viral and nonviral vaccines have been tested in preclinical and clinical models with variable success. However, the development of new delivery methods, such as electroporation, as well as the use of agents that improve antigen uptake or presentation, and the optimization of the transgene sequences, are overcoming historical drawbacks. Efficacy and safety issues of the in vivo use of DNA-based vaccines, as well as data from preclinical and recent clinical studies, are discussed. Novel developments will improve clinical efficacy, with the potential for DNA vaccination to enter in to the arsenal of cancer therapies in the near future.
Insights
DNA vaccines offer a novel approach to cancer treatment by stimulating immunity against tumor antigens. Advances in delivery and optimization are improving efficacy, positioning DNA vaccination as a future cancer therapy.
Area of Science:
- Oncology
- Immunology
- Vaccinology
Background:
- DNA vaccine therapies represent a novel strategy for cancer treatment.
- The goal is to induce an immune response against tumor-associated antigens.
- Both viral and nonviral DNA vaccines have shown variable success in preclinical and clinical studies.
Purpose of the Study:
- This review focuses on DNA vaccine approaches for cancer prevention and treatment.
- It discusses the efficacy and safety of in vivo DNA-based vaccines.
- The review highlights recent advancements and future potential of DNA vaccination in oncology.
Main Methods:
- The review synthesizes data from preclinical and clinical studies on DNA vaccines.
- It examines various delivery methods, including electroporation.
- Optimization of antigen uptake, presentation, and transgene sequences are discussed.
Main Results:
- Historical drawbacks of DNA vaccines are being overcome by new delivery methods and optimization strategies.
- Variable success has been observed in preclinical and clinical models.
- Ongoing developments are enhancing the clinical efficacy of DNA-based cancer vaccines.
Conclusions:
- DNA vaccination holds significant potential for cancer treatment.
- Novel developments are improving the clinical efficacy and safety of these vaccines.
- DNA vaccines may soon become a valuable addition to the cancer therapy arsenal.
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Gene Therapy
Gene Therapy
Tumor Immunotherapy
Microorganisms in Medicine and Therapeutics
Targeted Cancer Therapies
There are several types of targeted therapies against specific...